Leslie Renee Ravestein - 20 May 2026 Form 4 Insider Report for Merlin, Inc. (MRLN)

Reporting relationship: CLO and Secretary
Issuer ticker: MRLN
Reported as of: 20 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 22 May 2026, 07:26:47 UTC
Prior SEC filing: 18 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Leslie Renee Ravestein

Key filing fact

Leslie Renee Ravestein filed Form 4 for Merlin, Inc. (MRLN) on 22 May 2026.

Key facts

This page summarizes Leslie Renee Ravestein's Form 4 filing for Merlin, Inc. (MRLN).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 22 May 2026, 07:26.

Change

Previous filing in this sequence was filed on 18 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002117606 Primary reporting owner

Ravestein Leslie Renee

Relationship: CLO and Secretary
Address: 100 CAUSEWAY STREET, 23RD FLOOR, BOSTON
Signature: /s/ Leslie Renee Ravestein
Signature date: 22 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MRLN transaction

Common stock

Award

Transaction value
Shares: +199,036
Change %
Price
Shares after: 199,036
Date: 20 May 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MRLN transaction Derivative

Stock Option

Award

Transaction value
Shares: +205,475
Change %
Price: $0.000000^*
Shares after: 205,475
Date: 20 May 2026
Ownership: Direct
Underlying class: Common stock
Underlying amount: 205,475
Exercise price: $6.64
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents an award of (i) 184,036 restricted stock units (RSUs), which vest in three equal annual installments beginning on March 16, 2027, and (ii) 15,000 RSUs, which vest in four equal installments every six months beginning on September 16, 2026. Each RSU represents a contingent right to receive one share of Common Stock. The RSUs do not expire.

Footnote F2

The stock option vests as to 25% of the underlying shares on November 12, 2026, and the remaining will vest in 36 substantially equal monthly installments thereafter.